CODX Stock Analysis: Buy, Sell, or Hold?
CODX - Co-Diagnostics, Inc. Common Stock
$1.54
-0.08 (-4.94%)
▼
5d:
-23.76%
30d:
-74.46%
90d:
+292.76%
WAIT
LOW Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: Mar 31, 2026
0d
Smart Money Accumulation
CODX is down 8.6% this week, but smart money is accumulating calls. Top strike: $2 2026-05-15 with 87 OI. Call ratio: 100% View Scanner →
Strength: 9.3/10
Get Alerted When CODX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CODX is down 23.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CODX is down 23.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CODX is currently trading at $1.54, which is considered oversold relative to its 30-day fair value range of $1.78 to $2.69.
Technical Outlook: Technically, CODX is in a uptrend. Immediate support is located at $1.45, while resistance sits at $3.95. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: CODX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Implied Volatility is high (100th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $45.00 (+2822.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CODX is in a uptrend. Immediate support is located at $1.45, while resistance sits at $3.95. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: CODX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Implied Volatility is high (100th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $45.00 (+2822.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.78 -
$2.69
Company Quality Score
52/100
(HOLD)
Options IV Signal
100th percentile
(EVENT RISK)
Volume Confirmation
HIGH
Confidence Score
70.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Options expensive (IV 100th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.9%)
- BULLISH: Trading 2822.1% below Wall St target ($45.00)
- WARNING: Recommendation downgraded due to -23.8% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$1.78 -
$2.69
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$1.30
(84.5%)
Support & Resistance Levels
Support Level
$1.45
Resistance Level
$3.95
Current Trend
Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.13
Wall Street Target
$45.00
(+2822.1%)
Revenue Growth (YoY)
76.7%
Earnings Growth (YoY)
30.8%
Share & Embed Analysis
Last updated: April 02, 2026 8:55 PM ET
Data refreshes hourly during market hours. Next update: 9:55 PM
Data refreshes hourly during market hours. Next update: 9:55 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CODX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 60 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 61 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 47 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$354 | 52 HOLD |
